165 related articles for article (PubMed ID: 128546)
41. Membranous nephropathy. Long-term follow-up and association with neoplasia.
Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
[TBL] [Abstract][Full Text] [Related]
42. [The dynamics of the changes in the ultrastructural organization of the podocytes in the primary nephrotic syndrome in children].
Val'kovich EI
Arkh Patol; 1990; 52(2):14-8. PubMed ID: 2353894
[TBL] [Abstract][Full Text] [Related]
43. Single and multiple drug therapy in autologous immune complex nephritis in rats.
Kupor LR; Lowance DC; McPhaul JJ
J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575
[TBL] [Abstract][Full Text] [Related]
44. Collagenofibrotic glomerulonephropathy with fibronectin deposition in a dog.
Kamiie J; Yasuno K; Ogihara K; Nakamura A; Tamahara S; Fujino Y; Ono K; Shirota K
Vet Pathol; 2009 Jul; 46(4):688-92. PubMed ID: 19276051
[TBL] [Abstract][Full Text] [Related]
45. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
46. Experimental ampicillin glomerulonephropathy.
Wright NG; Nash AS
J Comp Pathol; 1984 Jul; 94(3):357-61. PubMed ID: 6236237
[TBL] [Abstract][Full Text] [Related]
47. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 41-1973.
N Engl J Med; 1973 Dec; 289(23):1241-7. PubMed ID: 4270649
[No Abstract] [Full Text] [Related]
48. Nephrotic syndrome in the cat due to diffuse membranous glomerulonephritis.
Farrow BR; Huxtable CR; McGovern VJ
Pathology; 1969 Jan; 1(1):67-72. PubMed ID: 5408671
[No Abstract] [Full Text] [Related]
49. Membranous nephropathy in the cat: a clinical and pathological study.
Nash AS; Wright NG; Spencer AJ; Thompson H; Fisher EW
Vet Rec; 1979 Jul; 105(4):71-7. PubMed ID: 552741
[TBL] [Abstract][Full Text] [Related]
50. Nephrotic syndrome in a dog.
Larkin HA; Lucke VM; Kidder DE
J Small Anim Pract; 1972 Jun; 13(6):333-7. PubMed ID: 5077657
[No Abstract] [Full Text] [Related]
51. Consensus recommendations for immunosuppressive treatment of dogs with glomerular disease based on established pathology.
; Segev G; Cowgill LD; Heiene R; Labato MA; Polzin DJ
J Vet Intern Med; 2013; 27 Suppl 1():S44-54. PubMed ID: 24635379
[TBL] [Abstract][Full Text] [Related]
52. Some unusual features of mesangioproliferative glomerulonephritis in horses.
Sabnis SG; Gunson DE; Antonovych TT
Vet Pathol; 1984 Nov; 21(6):574-81. PubMed ID: 6516178
[TBL] [Abstract][Full Text] [Related]
53. Nephrotic syndrome and collagenizing glomerulopathy in PVG/c rats treated with the alpha-mannosidase inhibitor "swainsonine".
Huxtable CR; Dorling PR
Vet Pathol; 1983 Nov; 20(6):727-36. PubMed ID: 6417878
[TBL] [Abstract][Full Text] [Related]
54. Resolution of diffuse membranous changes with remission of nephrotic syndrome.
Osawa G; Kinoshita Y; Morita T; Soda T; Wada J
Tohoku J Exp Med; 1976 Oct; 120(2):177-90. PubMed ID: 982435
[TBL] [Abstract][Full Text] [Related]
55. Nephrotic syndrome in dogs: clinical features and evidence-based treatment considerations.
Klosterman ES; Pressler BM
Top Companion Anim Med; 2011 Aug; 26(3):135-42. PubMed ID: 21782144
[TBL] [Abstract][Full Text] [Related]
56. Progression of glomerulonephritis to end-stage kidney disease in a cat with nephrotic syndrome.
Kamiie J; Haishima A; Inoue K; Ogihara K; Ono M; Yasuno K; Kobayashi R; Aihara N; Ohmuro T; Shirota K
J Vet Med Sci; 2011 Jan; 73(1):129-32. PubMed ID: 20823662
[TBL] [Abstract][Full Text] [Related]
57. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992).
Cook AK; Cowgill LD
J Am Anim Hosp Assoc; 1996; 32(4):313-22. PubMed ID: 8784722
[TBL] [Abstract][Full Text] [Related]
58. Glomerular deposition of immune complexes in dogs following natural infection with canine adenovirus.
Morrison WI; Nash AS; Wright NG
Vet Rec; 1975 Jun; 96(24):522-4. PubMed ID: 166480
[TBL] [Abstract][Full Text] [Related]
59. Treatment of membranoproliferative glomerulonephritis and nephrotic syndrome in a dog with a thromboxane synthetase inhibitor.
Grauer GF; Frisbie DD; Snyder PS; Dubielzig RR; Panciera DL
J Vet Intern Med; 1992; 6(2):77-81. PubMed ID: 1588545
[TBL] [Abstract][Full Text] [Related]
60. World Small Animal Veterinary Association Renal Pathology Initiative: Classification of Glomerular Diseases in Dogs.
Cianciolo RE; Mohr FC; Aresu L; Brown CA; James C; Jansen JH; Spangler WL; van der Lugt JJ; Kass PH; Brovida C; Cowgill LD; Heiene R; Polzin DJ; Syme H; Vaden SL; van Dongen AM; Lees GE
Vet Pathol; 2016 Jan; 53(1):113-35. PubMed ID: 25957358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
